BeStock  
Stocks › Biotechnology › VKTX

Viking Therapeutics VKTX

US equityMarket cap rank #2398Biotechnology
$24.77 −$1.07 (-4.14%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.10 +1.33%
Open$25.62
Prev close$25.84
Day range$24.67 – $26.50
Volume3.65M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

VKTX Stock News

Headlines matching Viking Therapeutics or the VKTX ticker, most recent first.

  • B. Riley Securities Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $85Market news · 9 Sep 2026 · Direct mention
  • Viking Therapeutics | 8-K: Current reportSEC · 29 Sep 2026 · Related
  • Viking Therapeutics | 424B5: ProspectusSEC · 25 Sep 2026 · Related
  • Viking Therapeutics | 424B5: ProspectusSEC · 25 Sep 2026 · Related
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $70 to $114Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $87 to $125Market news · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) and Aytu BioScience (AYTU)TipRanks · 23 Sep 2026 · Direct mention
  • Analysts Are Bullish on Top Healthcare Stocks: Maze Therapeutics, Inc. (MAZE), Viking Therapeutics (VKTX) PositiveTipRanks · 23 Sep 2026 · Direct mention
  • Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100Market news · 3 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $100Market news · 14 Aug 2026 · Direct mention
  • J.P. Morgan Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Cuts Target Price to $65 NegativeMarket news · 11 Aug 2026 · Direct mention
  • Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $70Market news · 1 Aug 2026 · Direct mention
  • Piper Sandler Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $71Market news · 7 Jul 2026 · Direct mention
  • Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $101Market news · 30 Jul 2026 · Direct mention
  • A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $71 to $114Market news · 30 Jul 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on VKTX.

Sign in to join the discussion.

Scroll to Top